Can an Aerosol Ointment Alleviate Dry Skin?

02/10/2018
spray

An aerosol ointment, Aquaphor Ointment Body Spray (OBS), effectively alleviated dry skin among patients with eczema, psoriasis, ichthyosis, and xerosis, according to the findings of a recent study presented at the 2018 Winter Clinical Dermatology Conference.

In the study, 80 patients with eczema, psoriasis, ichthyosis, or xerosis, including 17 children aged 1 to 12 years and 10 adolescents aged 13 to 18 years, applied the OBS at least once a day to very dry skin. At baseline and approximately 2 weeks after initiating treatment, the researchers graded the efficacy of the OBS based on dryness, scaling, and cracking, and irritation parameters, which included burning, itching, tightness, and erythema, using a 5-point scale.

After a mean 16.2 days of treatment, patients who used the product daily showed significant improvements in the clinical grading scores and irritation parameters. The majority of patients saw improvements in symptom severity, with 35% of patients experiencing complete resolution of dryness, 51.4% experiencing complete resolution of scaling, and 60% experiencing complete resolution of cracking. In addition, the majority of patients experienced only slight or no symptoms of irritation at the end of treatment.

No adverse events were reported, and no patients experienced worsening of symptoms, with 100% of patients exhibiting “good” to “very good” tolerability. Overall, 95% of patients reported they would continue using OBS.

In addition, physicians reported an overall improvement for 100% of patients and indicated that OBS exhibited “good” or “very good” efficacy for alleviating dry skin for 98.8% of patients.

“OBS provides an effective option for the adjunctive moisturizing treatment of multiple skin conditions in both children and adults,” the researchers concluded.

—Melissa Weiss

Reference

Weber TM, Arrowitz CE, Scherdin U, Schoelermann AM, Filbry A. A moisturizing spray ointment to help alleviate dry skin symptoms associated with atopic eczema, psoriasis, and xerosis. Presented at: The Winter Clinical Dermatology Conference; January 12-17, 2018; Maui, Hawaii.